T4	total-participants 1177 1188	seventy-six
T5	eligibility 1189 1208	premenopausal women
T6	control 1239 1246	placebo
T8	outcome 1414 1438	breast density reduction
T9	iv-bin-percent 1440 1443	60%
T10	cv-bin-percent 1448 1450	9%
T1	intervention 18 64	boswellia, betaine and myo-inositol (Eumast√≥s)
